Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-04

Clinical Trial Update: Indocyanine Green (ICG) Guided Tumor Resection [Phase 1]

View source ↗

Summary

This clinical trial entry describes a Phase 1 study evaluating Indocyanine Green (ICG) guided tumor resection in patients with neoplastic diseases and solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Neoplastic Disease, Solid Tumor | Phase 1 | Status: RECRUITING